Open Access
Open access
Molecules, volume 24, issue 9, pages 1722

Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats

Plotnikov Mark B. 1, 2
Chernysheva Galina A. 1
Aliev Oleg I. 1
Smoliakova Vera I 1
Fomina Tatiana I 3
Osipenko Anton N 4
Rydchenko Victoria S 5
Anfinogenova Y. J. 6, 7
Schepetkin Igor A. 7, 9
Atochin Dmitriy N 7, 10
Publication typeJournal Article
Publication date2019-05-03
Journal: Molecules
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor4.6
ISSN14203049
Organic Chemistry
Drug Discovery
Physical and Theoretical Chemistry
Pharmaceutical Science
Molecular Medicine
Analytical Chemistry
Chemistry (miscellaneous)
Abstract
c-Jun N-terminal kinase (JNK) is activated by various brain insults and is implicated in neuronal injury triggered by reperfusion-induced oxidative stress. Some JNK inhibitors demonstrated neuroprotective potential in various models, including cerebral ischemia/reperfusion injury. The objective of the present work was to study the neuroprotective activity of a new specific JNK inhibitor, IQ-1S (11H-indeno[1,2-b]quinoxalin-11-one oxime sodium salt), in the model of global cerebral ischemia (GCI) in rats compared with citicoline (cytidine-5′-diphosphocholine), a drug approved for the treatment of acute ischemic stroke and to search for pleiotropic mechanisms of neuroprotective effects of IQ-1S. The experiments were performed in a rat model of ischemic stroke with three-vessel occlusion (model of 3VO) affecting the brachiocephalic artery, the left subclavian artery, and the left common carotid artery. After 7-min episode of GCI in rats, 25% of animals died, whereas survived animals had severe neurological deficit at days 1, 3, and 5 after GCI. At day 5 after GCI, we observing massive loss of pyramidal neurons in the hippocampal CA1 area, increase in lipid peroxidation products in the brain tissue, and decrease in local cerebral blood flow (LCBF) in the parietal cortex. Moreover, blood hyperviscosity syndrome and endothelial dysfunction were found after GCI. Administration of IQ-1S (intragastrically at a dose 50 mg/kg daily for 5 days) was associated with neuroprotective effect comparable with the effect of citicoline (intraperitoneal at a dose of 500 mg/kg, daily for 5 days).The neuroprotective effect was accompanied by a decrease in the number of animals with severe neurological deficit, an increase in the number of animals with moderate degree of neurological deficit compared with control GCI group, and an increase in the number of unaltered neurons in the hippocampal CA1 area along with a significant decrease in the number of neurons with irreversible morphological damage. In rats with IQ-1S administration, the LCBF was significantly higher (by 60%) compared with that in the GCI control. Treatment with IQ-1S also decreases blood viscosity and endothelial dysfunction. A concentration-dependent decrease (IC50 = 0.8 ± 0.3 μM) of tone in isolated carotid arterial rings constricted with phenylephrine was observed after IQ-1S application in vitro. We also found that IQ-1S decreased the intensity of the lipid peroxidation in the brain tissue in rats with GCI. 2.2-Diphenyl-1-picrylhydrazyl scavenging for IQ-1S in acetonitrile and acetone exceeded the corresponding values for ionol, a known antioxidant. Overall, these results suggest that the neuroprotective properties of IQ-1S may be mediated by improvement of cerebral microcirculation due to the enhanced vasorelaxation, beneficial effects on blood viscosity, attenuation of the endothelial dysfunction, and antioxidant/antiradical IQ-1S activity.

Citations by journals

1
2
3
Biomedicines
Biomedicines, 3, 8.57%
Biomedicines
3 publications, 8.57%
Molecules
Molecules, 3, 8.57%
Molecules
3 publications, 8.57%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 5.71%
International Journal of Molecular Sciences
2 publications, 5.71%
Cells
Cells, 2, 5.71%
Cells
2 publications, 5.71%
Human Vaccines and Immunotherapeutics
Human Vaccines and Immunotherapeutics, 2, 5.71%
Human Vaccines and Immunotherapeutics
2 publications, 5.71%
ACS Omega
ACS Omega, 1, 2.86%
ACS Omega
1 publication, 2.86%
Bioanalysis
Bioanalysis, 1, 2.86%
Bioanalysis
1 publication, 2.86%
Biomolecules
Biomolecules, 1, 2.86%
Biomolecules
1 publication, 2.86%
Chinese Medicine
Chinese Medicine, 1, 2.86%
Chinese Medicine
1 publication, 2.86%
Hypertension Research
Hypertension Research, 1, 2.86%
Hypertension Research
1 publication, 2.86%
Cell Death and Disease
Cell Death and Disease, 1, 2.86%
Cell Death and Disease
1 publication, 2.86%
Inorganica Chimica Acta
Inorganica Chimica Acta, 1, 2.86%
Inorganica Chimica Acta
1 publication, 2.86%
Journal of Molecular Structure
Journal of Molecular Structure, 1, 2.86%
Journal of Molecular Structure
1 publication, 2.86%
Journal of Stroke and Cerebrovascular Diseases
Journal of Stroke and Cerebrovascular Diseases, 1, 2.86%
Journal of Stroke and Cerebrovascular Diseases
1 publication, 2.86%
European Polymer Journal
European Polymer Journal, 1, 2.86%
European Polymer Journal
1 publication, 2.86%
European Journal of Pharmacology
European Journal of Pharmacology, 1, 2.86%
European Journal of Pharmacology
1 publication, 2.86%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 1, 2.86%
Bioorganic and Medicinal Chemistry
1 publication, 2.86%
ACS Biomaterials Science and Engineering
ACS Biomaterials Science and Engineering, 1, 2.86%
ACS Biomaterials Science and Engineering
1 publication, 2.86%
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 1, 2.86%
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
1 publication, 2.86%
Iranian Red Crescent Medical Journal, 1, 2.86%
Iranian Red Crescent Medical Journal
1 publication, 2.86%
Arterial Hypertension (Russian Federation)
Arterial Hypertension (Russian Federation), 1, 2.86%
Arterial Hypertension (Russian Federation)
1 publication, 2.86%
Journal of Evolutionary Biochemistry and Physiology
Journal of Evolutionary Biochemistry and Physiology, 1, 2.86%
Journal of Evolutionary Biochemistry and Physiology
1 publication, 2.86%
Pharmaceutics
Pharmaceutics, 1, 2.86%
Pharmaceutics
1 publication, 2.86%
Research Results in Pharmacology
Research Results in Pharmacology, 1, 2.86%
Research Results in Pharmacology
1 publication, 2.86%
Pharmaceuticals
Pharmaceuticals, 1, 2.86%
Pharmaceuticals
1 publication, 2.86%
Advances in Clinical Medicine
Advances in Clinical Medicine, 1, 2.86%
Advances in Clinical Medicine
1 publication, 2.86%
Neurochemical Journal
Neurochemical Journal, 1, 2.86%
Neurochemical Journal
1 publication, 2.86%
Bulletin of Experimental Biology and Medicine
Bulletin of Experimental Biology and Medicine, 1, 2.86%
Bulletin of Experimental Biology and Medicine
1 publication, 2.86%
1
2
3

Citations by publishers

2
4
6
8
10
12
14
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 13, 37.14%
Multidisciplinary Digital Publishing Institute (MDPI)
13 publications, 37.14%
Elsevier
Elsevier, 6, 17.14%
Elsevier
6 publications, 17.14%
Springer Nature
Springer Nature, 4, 11.43%
Springer Nature
4 publications, 11.43%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 5.71%
American Chemical Society (ACS)
2 publications, 5.71%
Taylor & Francis
Taylor & Francis, 2, 5.71%
Taylor & Francis
2 publications, 5.71%
Pleiades Publishing
Pleiades Publishing, 2, 5.71%
Pleiades Publishing
2 publications, 5.71%
Future Medicine
Future Medicine, 1, 2.86%
Future Medicine
1 publication, 2.86%
Media Sphere Publishing Group
Media Sphere Publishing Group, 1, 2.86%
Media Sphere Publishing Group
1 publication, 2.86%
DoNotEdit, 1, 2.86%
DoNotEdit
1 publication, 2.86%
Almazov National Medical Research Centre
Almazov National Medical Research Centre, 1, 2.86%
Almazov National Medical Research Centre
1 publication, 2.86%
Belgorod National Research University
Belgorod National Research University, 1, 2.86%
Belgorod National Research University
1 publication, 2.86%
Hans Publishers
Hans Publishers, 1, 2.86%
Hans Publishers
1 publication, 2.86%
2
4
6
8
10
12
14
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Plotnikov M. B. et al. Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats // Molecules. 2019. Vol. 24. No. 9. p. 1722.
GOST all authors (up to 50) Copy
Plotnikov M. B., Chernysheva G. A., Aliev O. I., Smoliakova V. I., Fomina T. I., Osipenko A. N., Rydchenko V. S., Anfinogenova Y. J., Khlebnikov A. I., Schepetkin I. A., Atochin D. N. Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats // Molecules. 2019. Vol. 24. No. 9. p. 1722.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/molecules24091722
UR - https://doi.org/10.3390%2Fmolecules24091722
TI - Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats
T2 - Molecules
AU - Plotnikov, Mark B.
AU - Chernysheva, Galina A.
AU - Aliev, Oleg I.
AU - Smoliakova, Vera I
AU - Fomina, Tatiana I
AU - Osipenko, Anton N
AU - Schepetkin, Igor A.
AU - Atochin, Dmitriy N
AU - Rydchenko, Victoria S
AU - Anfinogenova, Y. J.
AU - Khlebnikov, Andrei I.
PY - 2019
DA - 2019/05/03 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 1722
IS - 9
VL - 24
PMID - 31058815
SN - 1420-3049
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Plotnikov,
author = {Mark B. Plotnikov and Galina A. Chernysheva and Oleg I. Aliev and Vera I Smoliakova and Tatiana I Fomina and Anton N Osipenko and Igor A. Schepetkin and Dmitriy N Atochin and Victoria S Rydchenko and Y. J. Anfinogenova and Andrei I. Khlebnikov},
title = {Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats},
journal = {Molecules},
year = {2019},
volume = {24},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {may},
url = {https://doi.org/10.3390%2Fmolecules24091722},
number = {9},
pages = {1722},
doi = {10.3390/molecules24091722}
}
MLA
Cite this
MLA Copy
Plotnikov, Mark B., et al. “Protective Effects of a New C-Jun N-terminal Kinase Inhibitor in the Model of Global Cerebral Ischemia in Rats.” Molecules, vol. 24, no. 9, May. 2019, p. 1722. https://doi.org/10.3390%2Fmolecules24091722.
Found error?